TMSB4X Drop During Hair Cell Differentiation

Concept

When supporting cells (progenitors) in the inner-ear sensory epithelium differentiate into hair cells, they rapidly assemble an elaborate F-actin cytoskeleton (stereocilia bundle) without significantly upregulating actin-gene transcription (Tilney & Tilney 1988). The mechanism Zhu et al. propose, supported by their single-cell proteomics + scRNA-seq data: the actin-monomer-buffering protein TMSB4X is downregulated, releasing previously-sequestered G-actin monomers for polymerization into stereocilia.

Why the concept matters

  • Reframes hair-cell biogenesis from a transcriptional problem to a post-translational availability problem.
  • Identifies TMSB4X as a developmental switch for actin cytoskeleton remodeling.
  • Establishes that endogenous WH2-class / β-thymosin-class actin sequestration is the dominant control point for free G-actin in hair cells.

Evidence (from Zhu 2019)

  1. Proteomics (single-cell, n=30 + 20-cell pools): TMSB4X riBAQ drops 9.3× from supporting cells (0.056) to hair cells (0.006). p < 0.001.
  2. scRNA-seq (n=254, post-QC): TMSB4X transcript is high in progenitor cells and nearly undetectable in striolar hair cells, downregulated immediately after the ATOH1 transcriptional pulse marking commitment to hair-cell fate.
  3. CellTrails pseudotime: TMSB4X expression decreases monotonically along the developmental trajectory, mirror image of OCM (mature hair-cell marker) which increases.
  4. Immunocytochemistry: TMSB4X immunoreactivity is strong cytoplasmic in supporting cells, substantially reduced in hair cells (Zhu 2019 Fig 3G–I).
  5. Total actin protein is similar in hair cells and supporting cells. Combined with the scRNA-seq finding that ACTB transcripts drop >10× during hair-cell differentiation, the inference is that hair cells use a slowed-synthesis + redistributed-pool strategy.

Implications for h09 hydrogel

  • The therapeutic target compartment (hair cells) has a low TMSB4X background — favorable for a synthetic WH2-peptide that competes for monomers.
  • Supporting cells, which a topical drug would also encounter (non-specific delivery), have near-equimolar TMSB4X with actin — large endogenous-buffer sink.
  • Differentiation timing: any therapy applied post-differentiation (Misha is years past the OHC differentiation window) sees the low-TMSB4X hair-cell state, not the high-buffer progenitor state. This is an argument for the recipe in Recipe — TMSB4X-Buffered Free G-actin Pool Estimation using hair-cell numbers.

Open questions

  • Is the same TMSB4X-drop pattern present in mammalian cochlear OHCs (the actual h09 target)? Zhu 2019 is chick utricle; chick utricle hair cells lack STRC-mediated horizontal top connectors. Mouse / human OHC TMSB4X dynamics have not been resolved at single-cell resolution.
  • Does the drop happen via degradation, transcriptional shutoff, or both? scRNA-seq suggests transcriptional; the apparent half-life rate of TMSB4X protein is not directly measured.
  • Tmsb10 and Tmsb15 paralog contribution in mammalian OHC is unresolved — chick gEAR data show Tmsb4x dominance, mouse cochlear data are lacking.

Connections